文献速递腹部CT

增强CT细胞外容积分数评估胰腺纤维化及其与胰腺癌的关系

Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer.
PubMed 文献 · Eur J Radiol · 2022-09-11

结果显示ECV与组织学纤维化分数显著相关(r=0.64,P<0.01),胰腺癌患者ECV更高(P<0.01),ECV诊断胰腺癌的截断值为32.8%,敏感度61.0%,特异度85.1%。ECV是多因素分析中胰腺癌的独立危险因素(OR=1.16,P<0.01)。

要点

  • 增强CT测量的胰腺ECV与组织学纤维化分数显著相关(r=0.64)。
  • 胰腺癌患者胰腺ECV高于其他疾病患者(P<0.01)。
  • ECV诊断胰腺癌截断值32.8%,敏感度61.0%,特异度85.1%。

核心结论

  • 胰腺ECV与组织学胰腺纤维化分数强相关,且是胰腺癌的独立危险因素(OR=1.16,P<0.01)。
  • ECV可作为反映胰腺纤维化进展的影像生物标志物,可能有助于预测胰腺癌发生,但需进一步研究。

研究设计与样本

  • 单中心回顾性研究,纳入88例连续患者(男48例,女40例;中位年龄69岁,范围17-89岁),其中胰腺癌47例,其他疾病41例。
  • 由两名委员会认证的放射科医生在预估切除线上测量胰腺实质ECV,参考标准为组织学纤维化分数。

诊断标准与关键数值

  • ECV与组织学胰腺纤维化分数显著相关(r=0.64,P<0.01)。
  • 胰腺癌患者ECV高于其他疾病患者(P<0.01)。
  • ROC分析显示ECV诊断胰腺癌的截断值为32.8%,敏感度61.0%,特异度85.1%。
  • 多因素分析中ECV是胰腺癌的独立危险因素(OR=1.16,P<0.01)。

临床应用与阅片要点

  • 可在增强CT图像上测量胰腺实质ECV,作为胰腺纤维化的无创评估指标。
  • ECV升高(截断值32.8%)提示胰腺癌风险增加,可辅助识别高危患者。
  • 测量时应选择非肿瘤胰腺实质区域,避免肿瘤本身影响ECV值。

局限性

  • 单中心回顾性研究,样本量有限(88例),需进一步多中心验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This study aimed to assess the relationship between pancreatic fibrosis measured by the extracellular volume fraction (ECV) using contrast-enhanced computed tomography (CT) and the histologic pancreatic fibrosis fraction and investigate the relationship between pancreatic fibrosis and pancreatic cancer.

METHOD: The study included 88 consecutive patients (48 males, 40 females; median age, 69 years; range, 17-89 years); 47 had pancreatic cancer, and 41 had other diseases. Fifty-two cases were evaluated pathologically for pancreatic fibrosis. The histologic pancreatic fibrosis fraction was quantified using image analysis software in nontumorous pancreatic tissue at the resection stump using 2-µm-thick Azan-stained slides. Two board-certified radiologists measured ECV in the pancreatic parenchyma at an estimated transection line. The correlation between histologic pancreatic fibrosis fraction and ECV was investigated, and whether the ECV value could be used as a biomarker for pancreatic cancer was investigated.

RESULTS: The histologic pancreatic fibrosis fraction was significantly correlated with the ECV (r = 0.64, P < 0.01). Pancreatic fibrosis evaluated by ECV was higher in pancreatic cancer patients than in other patients (P < 0.01). On receiver-operating characteristic curve analysis, the ECV had good diagnostic accuracy for the development of pancreatic cancer (cut-off value 32.8%; sensitivity 61.0%, specificity 85.1%). ECV was identified on multivariate analysis as an independent risk factor for pancreatic cancer (odds ratio 1.16; P < 0.01).

CONCLUSIONS: Extracellular volume fraction was strongly related to the histologic pancreatic fibrosis fraction, which was independently associated with pancreatic cancer. Thus, extracellular volume fraction is an imaging biomarker that reflects the progression of pancreatic fibrosis and may potentially help predict the development of pancreatic cancer, although further investigation will be needed.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Fukui, Onishi, Nakamoto, et al. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer. Eur J Radiol. 2022. PMID: 36113381. doi:10.1016/j.ejrad.2022.110522

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。